News | Radiation Oncology | September 21, 2020

Final rule includes mandatory participation for nearly 1,000 practices and does not allow sufficient time for transition

Final rule includes mandatory participation for nearly 1,000 practices and does not allow sufficient time for transition

Getty Images


September 21, 2020 — In response to the September 18 announcement by the Centers for Medicare and Medicaid Services (CMS) to establish an advanced alternative payment model (APM) for radiation oncology practices starting January 1, 2021, the American Society for Radiation Oncology (ASTRO) issued the following statement from Theodore L. DeWeese, M.D., FASTRO, Chair of the ASTRO Board of Directors:

"Achieving value-based care in radiation oncology that improves outcomes for cancer patients has been a longstanding goal of ASTRO. The final Radiation Oncology Model announced today by the Center for Medicare and Medicaid Innovation begins moving the specialty in that direction but fails to address many of the radiation oncology community's key concerns.

Requiring practices to participate and then forcing them to start the model on January 1, 2021, is untenable for practices already enduring staff shortages and other challenges due to the COVID-19 pandemic. The transition to value-based payment will require significant practice changes and investments to comply with the model's requirements. ASTRO strongly urges CMS to significantly delay the start date rather than foster unnecessary chaos and burden for the practices this model is designed to support. ASTRO also will be asking Congressional leaders to delay the RO Model via legislation before the end of the year.

ASTRO appreciates that CMS accepted some of the radiation oncology community's recommendations to minimally reduce the severe payment cuts from the initial proposal; however, we believe the Agency should have made additional modifications. For example, mandatory participation representing 30% of all radiation oncology episodes, while a positive step from the 40% originally proposed, still goes too far for an untested model and runs counter to our recommendation that CMS launch the model as voluntary, then transition to a mandatory model that includes opt-outs for low-volume practices and hardship exemptions.

ASTRO has worked with CMS and bipartisan legislators for several years toward a viable payment model for radiation oncology that would support stable and fair payments, drive adherence to nationally recognized clinical guidelines and improve patient care. We are hopeful that CMS and Congress are open to reconsidering a start date that would be realistic and not derail this unique opportunity. We also look forward to working with the Agency to improve future iterations of the model to ensure that patient access to radiation therapy services is not limited."

ASTRO's health policy experts are currently completing an in-depth analysis of the model. Additional comments and updates will be posted to www.astro.org/APMpress

Related Content

News | Proton Therapy

August 5, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, Fred ...

Time August 05, 2022
arrow
News | Radiology Business

August 4, 2022 — The Biden Administration, through the U.S. Department of Health and Human Services and the Centers for ...

Time August 04, 2022
arrow
News | Pediatric Imaging

August 3, 2022 — The Jack Martin Fund (JMF) has built on its partnership with the Mount Sinai Health System to provide ...

Time August 03, 2022
arrow
Feature | Oncology Information Management Systems (OIMS)

August 2, 2022 — The oncology information systems market is projected to be worth $2.59 Bn by 2022 and is expected to ...

Time August 02, 2022
arrow
Feature | Lung Imaging

August 1, 2022 — In recognition of World Lung Cancer Day, the American Lung Association announced new patient resources ...

Time August 01, 2022
arrow
News | Nuclear Imaging

July 27, 2022 — Patients for Safer Nuclear Medicine, a coalition of 29 patient advocacy organizations representing ...

Time July 27, 2022
arrow
News | Oncology Information Management Systems (OIMS)

July 26, 2022 — The oncology information system market is expected to expand at a 7.8% CAGR. The oncology information ...

Time July 26, 2022
arrow
News | Radiation Oncology

July 25, 2022 — RaySearch Laboratories AB announces the launch of RayStation* 12A, the latest version of the company’s ...

Time July 25, 2022
arrow
News | ECR

July 25, 2022 — Dunlee unveiled its new oncology bundles for the first time this year, launched at the 2022 European ...

Time July 25, 2022
arrow
Feature | Radiology Business

View the July/August digital edition of Imaging Technology News (ITN), including links to videos, comparison charts and ...

Time July 21, 2022
arrow
Subscribe Now